Initially, we attempted to detect immunoreactivity on dot-blot strips using a plasma pool from COVID-19-positive individuals in combination with both anti-IgG and anti-IgM secondary antibodies, each on a separate dot-blot strip. This evidence concerns the gene CD40LG and COVID-19.